483
Blossom PharmaceuticalsBlossom Pharmaceuticals – FDA 483, Apr 11, 2025
Record Details
Blossom Pharmaceuticals, an OTC drug manufacturer in Bardez, Goa, India, received a Form 483 for significant GMP deficiencies. The inspection revealed systemic failures in data integrity, process and cleaning validation, equipment maintenance, laboratory controls, environmental conditions, quality unit oversight, and personnel training. These issues indicate a profound lack of control over manufacturing processes and product quality.
View Company Profile
ID · 0d392295-6aa6-4e44-ac26-1d7eb1438b92
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.